SCHEMBL4349372

SCHEMBL4349372

Cc1c(Cl)cc(NC(=S)Nc2ccccc2)c(O)c1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
RAB9A P51151 2/20 0.55
NPC1 O15118 1/20 0.55
HTT P42858 1/20 0.55
CYP3A4 P08684 2/20 0.49
TAS2R38 P59533 1/20 0.49
HSD17B10 Q99714 1/20 0.49
KMT2A Q03164 2/20 0.46
LMNA P02545 2/20 0.46
GAA P10253 1/20 0.46
MAOA P21397 1/20 0.46
MAOB P27338 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MAPT P10636 2/20 0.45
HPGD P15428 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
KDM4E B2RXH2 1/20 0.45
POLB P06746 1/20 0.45
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4345472 0.89 ALDH1A1 (0.48) ALDH1A1RAB9ANPC1HTTKMT2A
SCHEMBL4353169 0.84 ALDH1A1 (0.55) ALDH1A1RAB9ANPC1HTTKMT2A
SCHEMBL4359810 0.83 MEN1 (0.56) ALDH1A1RAB9ANPC1HTTKMT2A
SCHEMBL4347865 0.83 MEN1 (0.46) ALDH1A1HTTCYP3A4KMT2ALMNA
SCHEMBL4351301 0.81 SMN1; SMN2 (0.60) ALDH1A1HTTLMNAGAAMAOB
SCHEMBL4357775 0.80 KMT2A (0.55) ALDH1A1RAB9ANPC1CYP3A4KMT2A
SCHEMBL4355451 0.79 ALDH1A1 (0.60) ALDH1A1RAB9ANPC1HTTCYP3A4
SCHEMBL4346849 0.78 ALDH1A1 (0.68) ALDH1A1RAB9ANPC1HTTCYP3A4
SCHEMBL4350883 0.77 MEN1 (0.59) ALDH1A1RAB9ANPC1HTTKMT2A
SCHEMBL4350106 0.77 POLB (0.52) ALDH1A1HTTCYP3A4KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 ALDH1A1 2565/4885RAB9A 4228/4885NPC1 815/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 ALDH1A1 2767/4885RAB9A 4588/4885NPC1 1189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.